Global Esketamine Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034

The Business Research Company's Esketamine Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, May 26, 2025 /EINPresswire.com/ -- The global esketamine market is witnessing a rapid expansion, poised to rise from $1.37 billion in 2024 to $1.52 billion in 2025. With an impressive compound annual growth rate CAGR of 11.2%, the market’s historic growth is linked to increasing patient numbers, rising mental health issues globally, enhanced disease awareness, escalating demand for unique therapeutic options, and favorable regulatory approvals.

What Is The Projected Growth Of The Esketamine Global Market?

In the upcoming years, the esketamine market size is predicted to have a swift growth. It is anticipated to reach $2.31 billion in 2029 at a CAGR of 11.0%. This growth is ascribed to several factors including the rising prevalence of treatment-resistant depression, an escalating investment in research and development, demand for smart healthcare infrastructure, the growing trend of telehealth services, as well as the growing acceptance of esketamine as an effective treatment. Novel trends in the forecast period include partnerships between biotech firms and mental health organizations, robotics in healthcare applications, personalized medicine strategies, sensor-based devices, and the potential for combination therapies.

How Does The Increase In Treatment-Resistant Depression Affect The Esktamine Market?

The prevalence of treatment-resistant depression TRD is playing a pivotal role in esketamine market growth. TRD refers to depression unresponsive to at least two different antidepressants taken at appropriate doses for sufficient duration. The increasing TRD cases arise from the limited efficacy of conventional antidepressants, leading to extended and recurrent depressive episodes. Esketamine provides a solution to this by presenting a fast-acting mechanism that targets NMDA receptors, bringing relief for patients resistant to traditional antidepressants.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23393&type=smp

Who Are The Influential Players In The Esketamine Market?
The industry is marked by several key players such as Cigna Corporation, Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sigma-Aldrich Corporation, Horizon Therapeutics plc, Hikma Pharmaceuticals plc, Cerecor Inc., Celon Pharma S.A., Nortec Química S.A., XWPharma Ltd., Seqens Group, SynZeal Research Pvt. Ltd., Arevipharma GmbH, Sage Therapeutics Inc., Supriya Lifescience Ltd., Clexio Biosciences Ltd., Maithri Drugs Pvt. Ltd., VistaGen Therapeutics Inc.

What Are The Latest Trends In The Esketamine Market?
Esketamine market players are concentrating their efforts in creating advanced solutions, such as monotherapy, to enhance depressive symptom relief beyond what placebo can offer. Monotherapy refers to the use of a single drug or treatment for managing a disease or medical condition, as opposed to combining multiple therapies.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/esketamine-global-market-report

How Is The Global Market For Esketamine Segmented?
The Esketamine market diversification is as follows:

By Type: Oral Medications, Injection, Nasal Spray, Other Types
By Indication: Major Depressive Disorder, Chronic Pain, Post-Traumatic Stress Disorder, Anxiety Disorders
By Patient Type: Adult Patients, Pediatric Patients, Geriatric Patients
By Application: General Anesthetic, Treatment-Resistant Depression
By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments include:
Oral Medications: Immediate-Release Tablets, Extended-Release Tablets, Sublingual Tablets
Injection: Intravenous Injection, Intramuscular Injection, Subcutaneous Injection
Nasal Spray: Prescription Nasal Spray, Over-The-Counter Nasal Spray, Combination Therapy Nasal Spray
Other Types: Plasmapheresis, Intravenous Immunoglobulin IVIG Therapy, Stem Cell Therapy

Where Is The Most Significant Growth Seen In The Global Esketamine Market?
In 2024, North America was the largest region in the esketamine market. Besides North America, the report also covers regions like Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Inhalation And Nasal Spray Generic Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/inhalation-and-nasal-spray-generic-drugs-global-market-report

Postpartum Depression Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Antidepressants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

About The Business Research Company
The Business Research Company makes reliable, accurate, and data-rich market reports from 27 industries covering 60+ geographies. Boasting of 1,500,000 datasets, insightful secondary research, and unique insights from industry leaders, we empower you with the information you need to be ahead in the game.

Find out more about us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X